Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Updated projections for COVID-19 omicron wave in Florida

View ORCID ProfileThomas J. Hladish, View ORCID ProfileAlexander N. Pillai, View ORCID ProfileIra M. Longini
doi: https://doi.org/10.1101/2022.01.06.22268849
Thomas J. Hladish
1Department of Biology, University of Florida
2Emerging Pathogens Institute, University of Florida
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thomas J. Hladish
  • For correspondence: tjhladish@ufl.edu ilongini@ufl.edu
Alexander N. Pillai
1Department of Biology, University of Florida
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alexander N. Pillai
Ira M. Longini
2Emerging Pathogens Institute, University of Florida
3Department of Biostatistics, University of Florida
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ira M. Longini
  • For correspondence: tjhladish@ufl.edu ilongini@ufl.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

In this report, we use a detailed simulation model to assess and project the COVID-19 epidemic in Florida. The model is a data-driven, stochastic, discrete-time, agent based model with an explicit representation of people and places. Using the model, we find that the omicron variant wave in Florida is likely to cause many more infections than occurred during the delta variant wave. Due to testing limitations and often mild symptoms, however, we anticipate that omicron infections will be underreported compared to delta. We project that reported cases of COVID-19 will continue to grow significantly and peak in early January 2022, and that the number of reported COVID-19 deaths due to omicron may be 1/3 of the total caused by the delta wave.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was partially funded by NIH grants R01AI139761 and R56AI148284.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study involves only openly available human data, which can be obtained from: CDC COVID Data Tracker, https://covid.cdc.gov/covid-data-tracker/#trends_dailycases

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All code used in the present study are available online at https://github.com/tjhladish/covid-abm All data produced in the present study are available upon reasonable request to the authors

https://github.com/tjhladish/covid-abm

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted January 06, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Updated projections for COVID-19 omicron wave in Florida
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Updated projections for COVID-19 omicron wave in Florida
Thomas J. Hladish, Alexander N. Pillai, Ira M. Longini
medRxiv 2022.01.06.22268849; doi: https://doi.org/10.1101/2022.01.06.22268849
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Updated projections for COVID-19 omicron wave in Florida
Thomas J. Hladish, Alexander N. Pillai, Ira M. Longini
medRxiv 2022.01.06.22268849; doi: https://doi.org/10.1101/2022.01.06.22268849

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (238)
  • Allergy and Immunology (521)
  • Anesthesia (124)
  • Cardiovascular Medicine (1418)
  • Dentistry and Oral Medicine (217)
  • Dermatology (158)
  • Emergency Medicine (291)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (582)
  • Epidemiology (10287)
  • Forensic Medicine (6)
  • Gastroenterology (527)
  • Genetic and Genomic Medicine (2625)
  • Geriatric Medicine (254)
  • Health Economics (496)
  • Health Informatics (1729)
  • Health Policy (789)
  • Health Systems and Quality Improvement (671)
  • Hematology (266)
  • HIV/AIDS (564)
  • Infectious Diseases (except HIV/AIDS) (12083)
  • Intensive Care and Critical Care Medicine (648)
  • Medical Education (273)
  • Medical Ethics (83)
  • Nephrology (288)
  • Neurology (2456)
  • Nursing (144)
  • Nutrition (377)
  • Obstetrics and Gynecology (491)
  • Occupational and Environmental Health (566)
  • Oncology (1319)
  • Ophthalmology (400)
  • Orthopedics (146)
  • Otolaryngology (235)
  • Pain Medicine (168)
  • Palliative Medicine (51)
  • Pathology (342)
  • Pediatrics (778)
  • Pharmacology and Therapeutics (329)
  • Primary Care Research (296)
  • Psychiatry and Clinical Psychology (2394)
  • Public and Global Health (4998)
  • Radiology and Imaging (893)
  • Rehabilitation Medicine and Physical Therapy (525)
  • Respiratory Medicine (681)
  • Rheumatology (309)
  • Sexual and Reproductive Health (255)
  • Sports Medicine (244)
  • Surgery (297)
  • Toxicology (45)
  • Transplantation (140)
  • Urology (108)